Dax E M, Clappison B H, Pullan P T, Pepperell R, Johnston C I
Clin Endocrinol (Oxf). 1979 Mar;10(3):253-63. doi: 10.1111/j.1365-2265.1979.tb02079.x.
Specific, homologous human neurophysin I and II radioimmunoassays were established and used to measure the individual, immunoreactive neurophysin concentrations in human plasma. Circulating levels of human neurophysin I in normal individuals were less than 1 ng/ml and neurophysin II levels were 1-2 ng/ml. During dehydration, there was a significant rise in plasma neurophysin I, together with an increase in neurophysin II. Haemorrhage also was associated with a rise in plasma neurophysin I and II, but the percent increase was greater for I than II. In two subjects in whom nicotine inhalation caused a rise in plasma neurophysin I, there was no detectable increase in plasma neurophysin II. These stimuli which have been reported to release vasopressin from the posterior pituitary also are associated with the differential release of neurophysin I. Plasma neurophysin II levels could more clearly be shown to rise independently of plasma neurophysin I during events thought to be related to oxytocin release. Plasma neurophysin II levels were significantly elevated in women taking oral contraceptives. Similarly during pregnancy there was a progressive rise in plasma neurophysin II concentration which was proportional to the period of gestation. Plasma neurophysin II concentrations in seven of fifteen nursing women rose significantly during suckling. There was no detectable change in plasma neurophysin I concentrations during any of these events. Plasma neurophysin I and II levels were both significantly elevated in fourteen patients with chronic renal failure and rose over haemodialysis, suggesting that the kidney may be the major route of clearance of the neurophysins. In humans the independent release of neurophysin II was associated with stimuli thought to release oxytocin, but neurophysin I showed only a differential release compared to neurophysin II in vasopressin stimulated events.
建立了特异性、同源性的人神经垂体素I和II放射免疫分析法,并用于测定人血浆中具有免疫反应性的神经垂体素的个体浓度。正常个体血浆中人神经垂体素I的循环水平低于1 ng/ml,神经垂体素II的水平为1 - 2 ng/ml。脱水期间,血浆神经垂体素I显著升高,同时神经垂体素II也增加。出血也与血浆神经垂体素I和II的升高有关,但I的升高百分比大于II。在两名吸入尼古丁导致血浆神经垂体素I升高的受试者中,血浆神经垂体素II未检测到升高。这些据报道可从垂体后叶释放血管加压素的刺激也与神经垂体素I的差异释放有关。在被认为与催产素释放相关的事件中,血浆神经垂体素II水平可更明显地显示出独立于血浆神经垂体素I而升高。服用口服避孕药的女性血浆神经垂体素II水平显著升高。同样,在怀孕期间,血浆神经垂体素II浓度逐渐升高,与妊娠期成正比。15名哺乳期妇女中有7名在哺乳期间血浆神经垂体素II浓度显著升高。在任何这些事件中,血浆神经垂体素I浓度均未检测到变化。14例慢性肾衰竭患者的血浆神经垂体素I和II水平均显著升高,且在血液透析过程中升高,提示肾脏可能是神经垂体素清除的主要途径。在人类中,神经垂体素II的独立释放与被认为可释放催产素的刺激有关,但在血管加压素刺激的事件中,与神经垂体素II相比,神经垂体素I仅表现出差异释放。